Cargando…

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?

SIMPLE SUMMARY: The WNT/β-catenin signaling pathway is involved in fundamental processes for the proliferation and differentiation of mesenchymal stem cells. However, little is known about its relevance for mesenchymal neoplasms, such us soft tissue sarcomas (STS). Chemotherapy based on doxorubicin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Font, Esther, Pérez-Capó, Marina, Vögler, Oliver, Martín-Broto, Javier, Alemany, Regina, Obrador-Hevia, Antònia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583315/ https://www.ncbi.nlm.nih.gov/pubmed/34771683 http://dx.doi.org/10.3390/cancers13215521

Ejemplares similares

Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas
por: Martinez-Font, Esther, et al.
Publicado: (2020)

Cancer Stem Cells in Soft-Tissue Sarcomas
por: Martínez-Delgado, Paula, et al.
Publicado: (2020)

Down-Regulation of AKT Signalling by Ursolic Acid Induces Intrinsic Apoptosis and Sensitization to Doxorubicin in Soft Tissue Sarcoma
por: Villar, Victor Hugo, et al.
Publicado: (2016)

Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas
por: Villar, Victor Hugo, et al.
Publicado: (2012)

TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
por: Martín-Medina, Aina, et al.
Publicado: (2022)

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
por: Liu, Jiaqi, et al.
Publicado: (2022)

Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcoma
por: Briski, Laurence M, et al.
Publicado: (2018)

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study
por: Fernandez-Serra, Antonio, et al.
Publicado: (2020)

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
por: McCubrey, J A, et al.
Publicado: (2014)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?
por: Puertas-Umbert, Lídia, et al.
Publicado: (2022)

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2023)

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
por: Planas‐Paz, Lara, et al.
Publicado: (2023)

Nature-derived compounds modulating Wnt/β-catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases
por: Sferrazza, Gianluca, et al.
Publicado: (2020)

LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling
por: Scannell, Christopher A., et al.
Publicado: (2013)

Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
por: Chen, Changbao, et al.
Publicado: (2015)

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2019)

EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2015)

Soft tissue sarcomas of the upper extremities: Maximizing treatment opportunities and outcomes
por: Duran-Moreno, Jose, et al.
Publicado: (2019)

Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
por: Hindi, Nadia, et al.
Publicado: (2020)

Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
por: Garcia del Muro, Xavier, et al.
Publicado: (2015)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
por: Jung, Youn-Sang, et al.
Publicado: (2020)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)
por: López-Pousa, A., et al.
Publicado: (2016)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
por: de Juan Ferré, A., et al.
Publicado: (2021)

Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies
por: de Bree, Eelco, et al.
Publicado: (2023)

The regulation of β-catenin activity and function in cancer: therapeutic opportunities
por: Shang, Shuang, et al.
Publicado: (2017)

Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma
por: Sha, Ying-Li, et al.
Publicado: (2019)

Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
por: Ram Makena, Monish, et al.
Publicado: (2019)

Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics
por: Pandey, Pratibha, et al.
Publicado: (2023)

A quest for therapeutic antigens in bone and soft tissue sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

The challenge of finding new therapeutic avenues in soft tissue sarcomas
por: Kasper, Bernd
Publicado: (2019)

Wnt/ß-Catenin: A New Therapeutic Approach to Acute Myeloid Leukemia
por: Kim, Y., et al.
Publicado: (2011)

Therapeutic strategies targeting Wnt/β-catenin signaling for colorectal cancer (Review)
por: Ji, Yong, et al.
Publicado: (2022)

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2016)

Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy
por: Piquer-Gil, Marina, et al.
Publicado: (2022)

The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities
por: Wu, Minjie, et al.
Publicado: (2023)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aqob7rt7kg629holfanomc3s73